SB
Publications
22
Views
13,764
Downloads
3,567
Supervised works
0
Items per page
1 - 22 of 22
Title Published in Access level OA Policy Year Views Downloads
A Systematic Review and Meta-Analysis of HCV ClearanceLiver international
accessLevelRestricted
2017 601 1
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant PopulationsPloS one
accessLevelPublic
2016 528 244
Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantationKidney international
accessLevelPublic
2016 495 585
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ TransplantClinical infectious diseases
accessLevelRestricted
2015 533 1
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesNature communications
accessLevelPublic
2015 578 164
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ TransplantationThe Journal of infectious diseases
accessLevelRestricted
2015 727 0
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ TransplantationThe Journal of infectious diseases
accessLevelRestricted
2015 675 2
The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infectionAlimentary pharmacology & therapeutics
accessLevelRestricted
2014 637 0
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patientsAIDS
accessLevelRestricted
2014 569 0
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesNature communications
accessLevelPublic
2014 675 1,237
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentPloS one
accessLevelPublic
2013 705 631
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinomaJournal of hepatology
accessLevelRestricted
2013 669 0
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance predictionThe Journal of experimental medicine
accessLevelRestricted
2013 570 0
IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4Journal of viral hepatitis
accessLevelRestricted
2013 641 0
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5Gut
accessLevelRestricted
2012 592 0
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapyHepatology
accessLevelRestricted
2012 642 0
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis CPloS one
accessLevelPublic
2012 764 395
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesHepatology
accessLevelRestricted
2012 657 0
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infectionGastroenterology
accessLevelRestricted
2012 630 0
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirinJournal of viral hepatitis
accessLevelRestricted
2012 628 0
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CJournal of hepatology
accessLevelRestricted
2011 612 0
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphismsPloS one
accessLevelPublic
2011 636 307
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack